ANL News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$710.3M

Volume

324.21K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and CetuximabAdlai Nortye announced clinical trial collaboration and supply agreements with Eli Lilly and Merck KGaA, Darmstadt, Germany to evaluate AN4035, a first-in-class pan-RAS(ON) inhibitor-based ADC, in combination with cetuximab in an ongoing global Phase I trial for CEACAM5-enriched RAS-addicted solid tumors. Both companies will supply cetuximab at no cost for their respective trial sites.GlobeNewswire Inc. · Oct 15, 2026

Adlai Nortye Announces $150.0 Million Private Placement Equity FinancingAdlai Nortye Ltd. (Nasdaq: ANL), a clinical-stage biotechnology company, announced a $150 million private placement of 11.32 million ADSs at $13.25 per share. The oversubscribed offering attracted participation from new institutional investors including Soleus Capital, Perceptive Advisors, and ADAR1 Capital Management, as well as existing investors. The company plans to use proceeds to advance its RAS-targeting therapies and next-generation cancer immunotherapies pipeline.GlobeNewswire Inc. · Apr 16, 2026

Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS MutationsAdlai Nortye Ltd. announced that the first patient has been dosed in the United States in its Phase 1 clinical trial of AN9025, an oral pan-RAS(ON) inhibitor for advanced solid tumors with RAS mutations. The trial is being conducted as a multi-regional clinical trial in collaboration with Jiangsu Aosaikang Pharmaceutical Co. Ltd., with Adlai Nortye retaining ex-China rights and ASK Pharm holding rights in mainland China, Hong Kong, and Macao.GlobeNewswire Inc. · Feb 12, 2026

Adlai Nortye to Participate in Upcoming Investor ConferencesAdlai Nortye, a clinical-stage biotechnology company, will participate in two healthcare investor conferences in late 2025 and early 2026, presenting its innovative cancer therapy pipeline.GlobeNewswire Inc. · Nov 21, 2025

Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsAdlai Nortye will present research on AN4035, a novel CEACAM5-targeting antibody drug conjugate, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on October 25, 2025.GlobeNewswire Inc. · Oct 14, 2025

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will present encouraging preliminary data of AN0025 in combination with definitive chemoradiotherapy (dCRT) in unresectable locally advanced or locally recurrent esophageal cancer (EC) at the upcoming American Society of Cancer Oncology (ASCO) Annual Meeting to be held in Chicago from May 31 to June 4, 2024.GlobeNewswire Inc. · May 24, 2024

Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year?Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Boston Scientific (BSX) have performed compared to their sector so far this year.Zacks Investment Research · May 15, 2024

Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Elevance Health (ELV) have performed compared to their sector so far this year.Zacks Investment Research · Apr 25, 2024

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionShares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 million versus expectations of $141.897 million. Skillsoft shares dipped 26.7% to $6.74 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers WiSA Technologies, Inc. (NASDAQ: WISA) jumped 85% to $3.2379 after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand. Palisade Bio, Inc. (NASDAQ: PALI) shares climbed 79.1% to $7.45 after the company announced the completion of analysis evaluating ex-vivo bioactivation of PALI-2108. Jaguar Health, Inc. (NASDAQ: JAGX) shares gained 67% to $0.1989 after the company signed an exclusive 5-year in-license agreement with Venture Life Group for Gelclair. Dynatronics Corporation (NASDAQ: DYNT) shares rose 44.4% to $0.5342 after dipping over 5% on Monday. IMAC Holdings, Inc. (NASDAQ: BACK) surged 40% to $4.69. Peraso Inc. (NASDAQ: PRSO) gained 38.8% to $1.75. Peraso recently announced that it received an additional $2.88 million purchase order. Macatawa Bank Corporation (NASDAQ: MCBC) rose 38.8% to $13.78 after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definitive merger agreement for Wintrust to acquire Macatawa in an all-stock transaction. China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 29.9% to ...Benzinga · Apr 16, 2024

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ: AUUD) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. Longeveron Inc. (NASDAQ: LGVN) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering. UTime Limited (NASDAQ: WTO) gained 56.8% to $0.29 after the company completed a private placement. U Power Limited (NASDAQ: UCAR) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China. Arrowroot Acquisition Corp. (NASDAQ: ARRW) rose 38.2% to $19.53. Destiny Tech100 Inc. (NASDAQ: DXYZ) jumped 33.8% to $79.30 after jumping around 77% on Friday. TechPrecision Corporation (NASDAQ: TPCS) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies. Adlai Nortye Ltd. (NASDAQ: ANL) gained 27.9% to $10.68. Connexa Sports Technologies Inc. (NASDAQ: CNXA) surged 26.8% to $0.3801. AXT, Inc. (NASDAQ: AXTI) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) climbed 24.4% to $8.70. Apartment Income REIT Corp. (NYSE: AIRC) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion. GD Culture Group Limited (NASDAQ: GDC) rose 22% to $1.1195. Outset Medical, Inc. ...Benzinga · Apr 8, 2024

ANLAdlai Nortye Group Ltd. American Depositary Shares

ANL

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any ANL yet.

Related Tickers

Earnings

Mkt Cap

$708.4M

Volume

324.21K